Lamivudine

Lamivudine

5.2 Moderate risk

Lamivudine & Lung cancer metastatic

8.3%

of users reported Lung cancer metastatic

91.3%

also reported Hospitalization

100.0%

are men

Most common medical consequences

Hospitalization
91.3%
Severe reaction
8.7%

Have you experienced any negative side effects from this medication?

Lamivudine: general information

Most common side effects (49)

Most commonly affected ages

0 - 9 years
1.2%
10 - 19 years
1.3%
20 - 29 years
2.1%
30 - 39 years
13.8%
40 - 49 years
20.2%
50 - 59 years
50.6%
60 - 69 years
7.7%
70 - 79 years
1.3%
80 - 89 years
1.8%